Ebola Outbreak Declared Emergency; Lack of Vaccine for Bundibugyo Strain Explained
Ebola Declared A Public Health Emergency, But Why Is There No Vaccine For Strain Driving The Outbreak?
Image: News 18
The World Health Organization declared the ongoing Ebola outbreak a Public Health Emergency of International Concern on May 16, 2026. The outbreak, driven by the Bundibugyo strain in the Democratic Republic of the Congo and Uganda, lacks a specific vaccine due to historical neglect, ineffective cross-protection from existing vaccines, and funding cuts impacting research and development.
- 01The Bundibugyo strain of Ebola has caused only two small outbreaks in history, leading to less research focus compared to the Zaire strain.
- 02Existing vaccines like Ervebo target the Zaire strain and offer only about 50% cross-efficacy against Bundibugyo.
- 03Experimental mRNA vaccine candidates for the Bundibugyo strain exist but have not yet undergone human clinical trials.
- 04The WHO estimates a timeline of six to nine months to fast-track new vaccine candidates for public use.
- 05Recent funding cuts to public health agencies have hindered the rapid development and deployment of medical countermeasures.
Advertisement
In-Article Ad
On May 16, 2026, the World Health Organization (WHO) declared the current Ebola outbreak a Public Health Emergency of International Concern (PHEIC). This outbreak is primarily affecting the Democratic Republic of the Congo and Uganda and is driven by the Bundibugyo strain, for which there is currently no licensed vaccine. Existing vaccines, such as Ervebo, are effective against the Zaire strain but do not provide adequate protection against Bundibugyo due to genetic differences. Historical data shows that the Bundibugyo strain has caused only two small outbreaks in 2007 and 2012, leading to less focus on its vaccine development. Although there are experimental mRNA vaccine candidates, they have not yet entered human trials, and the WHO estimates that it could take six to nine months to prepare viable doses for public use. Furthermore, recent funding cuts to health agencies have slowed the necessary financial support for rapid vaccine development and testing, complicating the global response to this emergency.
Advertisement
In-Article Ad
The lack of a vaccine for the Bundibugyo strain poses significant risks to public health in the affected regions, potentially leading to increased transmission and fatalities.
Advertisement
In-Article Ad
Reader Poll
How should global health organizations respond to the Ebola outbreak?
Connecting to poll...
More about World Health Organization
Read the original article
Visit the source for the complete story.